L-theanine and tetrahydrocannabinol formulation
OwnerSteven Robert Laviolette, Marta De Felice +2inventors
InventorsSteven Robert Laviolette, Marta De Felice, Richard Rusiniak, Paul Ramsay
Life of this patent
Estimating the term…
Abstract
A method is for use with a treatment regime that includes the exposure of a patient to THC. The method comprises the step of administering Theanine to the patient. The Theanine can be L-Theanine. The treatment regime can involve a plurality of administrations of THC and Theanine can be administered with each administration of THC. The method of administration can be such that the peak bioavailability of THC occurs substantially contemporaneously with the peak bioavailability of Theanine. A consumer package can be adapted for carrying out the method.
Claims7
A method used with a treatment regime that includes the exposure of a patient to THC, the method being for blocking THC-induced anhedonic depressive-like effects and comprising the step of
- administering Theanine to the patient.
A method used with a treatment regime involving a plurality of administrations of THC, the method being for blocking THC-induced anhedonic depressive-like effects and comprising the step of
- administering Theanine to the patient with each administration of THC.
Dependencies are inferred from the claim text.